APA (7th ed.) Citation

Z, K., M, J., M, C., R, M., V, M., JS, K., . . . T, B. (2023). Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy. Genome medicine, 15(1), 45. https://doi.org/10.1186/s13073-023-01193-4

Chicago Style (17th ed.) Citation

Z, Khan, et al. "Whole Genome Sequencing Across Clinical Trials Identifies Rare Coding Variants in GPR68 Associated with Chemotherapy-induced Peripheral Neuropathy." Genome Medicine 15, no. 1 (2023): 45. https://doi.org/10.1186/s13073-023-01193-4.

MLA (9th ed.) Citation

Z, Khan, et al. "Whole Genome Sequencing Across Clinical Trials Identifies Rare Coding Variants in GPR68 Associated with Chemotherapy-induced Peripheral Neuropathy." Genome Medicine, vol. 15, no. 1, 2023, p. 45, https://doi.org/10.1186/s13073-023-01193-4.